SPRB SPRUCE BIOSCIENCES INC revenue, earnings and financials

For the quarter ended June 30, 2026, SPRUCE BIOSCIENCES INC reported revenue of n/a, net income of −$16.2M and diluted EPS of −$6.68; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.

SPRB annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$36.5M, net income −$39.0M (margin n/a), EPS −$50.83
• Fiscal year ended Dec 2024: revenue $4.91M, gross profit n/a, operating income −$56.2M, net income −$53.0M (margin -1079.9%), EPS −$96.40
• Fiscal year ended Dec 2023: revenue $10.1M, gross profit n/a, operating income −$52.0M, net income −$47.9M (margin -475.0%), EPS −$1.24
• Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$47.3M, net income −$46.2M (margin n/a), EPS −$1.96
• Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$42.1M, net income −$42.3M (margin n/a), EPS −$1.81

SPRB quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue n/a, net income −$16.2M, EPS −$6.68
• Quarter ended Mar 31, 2026: revenue n/a, net income −$12.3M, EPS −$8.94
• Quarter ended Dec 31, 2025 (from the annual report): revenue $0 (down 100.0% year over year), net income −$14.6M, EPS −$8.80
• Quarter ended Sep 30, 2025: revenue $0 (down 100.0% year over year), net income −$8.21M, EPS −$14.58
• Quarter ended Jun 30, 2025: revenue $0 (down 100.0% year over year), net income −$2.07M, EPS −$3.50
• Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$14.0M, EPS −$23.95
• Quarter ended Dec 31, 2024 (from the annual report): revenue $697K (down 75.9% year over year), net income −$23.6M, EPS −$63.64
• Quarter ended Sep 30, 2024: revenue $602K (down 80.4% year over year), net income −$8.67M, EPS −$15.75
• Quarter ended Jun 30, 2024: revenue $1.61M (down 25.6% year over year), net income −$9.18M, EPS −$16.73
• Quarter ended Mar 31, 2024: revenue $2.00M (up 1.9% year over year), net income −$11.6M, EPS −$0.28
• Quarter ended Dec 31, 2023 (from the annual report): revenue $2.89M, net income −$9.95M, EPS −$0.22
• Quarter ended Sep 30, 2023: revenue $3.07M, net income −$12.4M, EPS −$0.30
• Quarter ended Jun 30, 2023: revenue $2.17M, net income −$12.8M, EPS −$0.32
• Quarter ended Mar 31, 2023: revenue $1.96M, net income −$12.8M, EPS −$0.40
• Quarter ended Dec 31, 2022 (from the annual report): revenue $0, net income −$11.1M, EPS −$0.47
• Quarter ended Sep 30, 2022: revenue $0, net income −$11.4M, EPS −$0.48
• Quarter ended Jun 30, 2022: revenue $0, net income −$11.9M, EPS −$0.51
• Quarter ended Mar 31, 2022: revenue $0, net income −$11.8M, EPS −$0.50
• Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$9.18M, EPS −$0.40
• Quarter ended Sep 30, 2021: revenue n/a, net income −$11.4M, EPS −$0.49

SPRB cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$33.3M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$56.0M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$33.3M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$41.7M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$35.9M, share buybacks n/a

SPRB balance sheet

• Jun 30, 2026: cash $96.3M, total assets $103M, total liabilities $19.1M, shareholders' equity $83.7M, long-term debt $4.59M
• Mar 31, 2026: cash $54.1M, total assets $56.2M, total liabilities $21.5M, shareholders' equity $34.6M, long-term debt $5.46M
• Dec 31, 2025: cash $48.9M, total assets $53.0M, total liabilities $10.5M, shareholders' equity $42.5M, long-term debt $0
• Sep 30, 2025: cash $10.7M, total assets $15.3M, total liabilities $9.93M, shareholders' equity $5.39M, long-term debt $0
• Jun 30, 2025: cash $16.4M, total assets $21.8M, total liabilities $8.64M, shareholders' equity $13.2M, long-term debt $0
• Mar 31, 2025: cash $25.6M, total assets $31.6M, total liabilities $16.3M, shareholders' equity $15.3M, long-term debt $0
• Dec 31, 2024: cash $38.8M, total assets $45.2M, total liabilities $16.4M, shareholders' equity $28.8M, long-term debt $124K
• Sep 30, 2024: cash $60.1M, total assets $65.1M, total liabilities $13.5M, shareholders' equity $51.6M, long-term debt $524K

What is SPRB's revenue?

SPRUCE BIOSCIENCES INC reported $0 of revenue for the fiscal year ended December 2025.

Is SPRB profitable?

No. SPRUCE BIOSCIENCES INC lost $51.4M over the last four quarters.

What is SPRB's EPS?

Diluted earnings per share over the last four quarters were −$39.00; −$6.68 in the latest quarter.

SPRB ownership and insider trades · All stocks